Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBT2 in early to mid-stage Huntington disease
NCT01590888Phase 2Completed
- Sponsor
- Alterity Therapeutics
- Start
- Apr 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of PBT2 in Huntington disease (HD), sponsored by Alterity Therapeutics. Started Apr 2012; status: completed.
02
Drugs
PBT2
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT01590888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01590888.